KERYX BIOPHARMACEU (NASDAQ:KERX)
2.27
0.04 (1.73%)
| KERYX BIOPHARMACEU (NASDAQ:KERX) Delayed : |
| Previous Close |
$2.31 |
|
52 Week High |
$3.45 |
|
| Open |
$2.35 |
|
52 Week Low |
$0.09 |
| Day High |
$2.36 |
|
P/E |
9.08 |
| Day Low |
$2.25 |
|
EPS |
$0.25 |
| Volume |
257,235 |
|
|
|
| More KERX Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on KERX
-
Feb 3, 2010 08:39 AM
Keryx Biopharma (KERX) Reaches Agreement with FDA Regarding SPA on Design of Phase 3 Trial for KRX-0401
-
Jan 29, 2010 08:57 AM
Æterna Zentaris (AEZS) and Partner Keryx Biopharma (KERX) Report on Phase 2 of Perifosine Waldenstrom's Macroglobulinemia Treatment
-
Jan 29, 2010 08:36 AM
Keryx Biopharmaceuticals (KERX) Announes Positive Phase 2 Study of Perifosine
-
Jan 25, 2010 10:54 AM
Morning Movers 1/25: SMTX, NBS, ERI, KFS, PVTB, CADC Higher; PARD, SNEN, BBX, PCBC Lower
-
Jan 25, 2010 08:52 AM
Keryx Biopharma (KERX) Updates on KRX-401 PI3K/Akt Pathway Inhibitor for Cancer
View All Reports
StreetInsider Reports on KERX by Category
Comments on recent KERX articles
Comments on KERX
No comments are currently available.
on Aug 3, 2009
at 03:40 PM Huron Consulting under investigation Hi All – Thought I’d provide a quick link for any investors reading this piece – I work for a law firm that’s investigating Huron on behalf of investors. You can learn more about the investigation here – www.hbsslaw.com/huron. HBSS is looking into possible issues with over-reported earnings, kickbacks to company insiders, and how and when the company notified shareholders.
Article: Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower